These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4367720)

  • 21. [Contribution to the problems of endangering of empolyees in the laboratory production of oxytocin and lysine-vasopressin].
    Kafka V; Mrázek J
    Cas Lek Cesk; 1969 Jun; 108(26):771-5. PubMed ID: 5786025
    [No Abstract]   [Full Text] [Related]  

  • 22. Milk ejecting effect induced by various octapeptides in human beings. Comparison between the milk ejecting potency of synthetic oxytocin, natural purified oxytocin, natural purified vasopressin and synthetic lysine-8-vasopressin.
    Sala NL
    Acta Physiol Lat Am; 1965; 15(2):191-9. PubMed ID: 5890375
    [No Abstract]   [Full Text] [Related]  

  • 23. [Natriuretic effect of vasopressin analogs].
    Borisova SA; Dubynina NN; Ivanova LN; Natochin IuV; Sokolova MM
    Fiziol Zh SSSR Im I M Sechenova; 1971 Jul; 57(7):1038-45. PubMed ID: 5565021
    [No Abstract]   [Full Text] [Related]  

  • 24. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
    Bernat A; Hoffmann P; Dumas A; Serradeil-le Gal C; Raufaste D; Herbert JM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of neurohypophysial hormones with their antisera.
    Vorherr H; Munsick RA
    J Clin Invest; 1970 Apr; 49(4):828-36. PubMed ID: 5443183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings: The factor VIII response to synthetic vasopressin analogues in man.
    Cash JD; Sas G
    Thromb Diath Haemorrh; 1975 Nov; 34(2):611. PubMed ID: 1198542
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
    Moffat EH; Giddings JC; Bloom AL
    Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lysine-vasopressin and adipokinesis in humans].
    Giordano G; Marcenaro A; Pompei A; Jacopino GE
    Arch Maragliano Patol Clin; 1970; 26(2):95-110. PubMed ID: 5537635
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: The uterotonic potency of vasopressin in the rat during the oestrous cycle and pregnancy.
    Heller H
    J Endocrinol; 1974 Nov; 63(2):42P. PubMed ID: 4443707
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intravenous administration of synthetic lysine-8-vasopressin and oxytocin. Effects on blood levels of growth hormone, follicle-stimulating hormone and insulin].
    Kleinknecht D; Rosselin G; Tchobroutsky G; Dolais J
    Presse Med (1893); 1969 May; 77(23):856-8. PubMed ID: 5806688
    [No Abstract]   [Full Text] [Related]  

  • 31. Antidiuretic activity and release of factor VIII by vasopressin analogues.
    Vilhardt H; Barth T; Melin P; Aurell CJ
    Eur J Pharmacol; 1993 Mar; 232(2-3):223-6. PubMed ID: 8467859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture.
    Beck TR; Hassid A; Dunn MJ
    J Pharmacol Exp Ther; 1980 Oct; 215(1):15-9. PubMed ID: 7452479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of vasopressin or oxytocin on thyroid-stimulating hormone and thyroid hormones' concentrations in blood plasma of euthyroid rats.
    Ciosek J; Stempniak B
    J Physiol Pharmacol; 1997 Dec; 48(4):813-23. PubMed ID: 9444627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli.
    Vicente V; Alberca I; Mannucci PM
    Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).
    Yamaguchi Y; Yamada K; Suzuki T; Wu YP; Kita K; Takahashi S; Ichinose M; Suzuki N
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E970-6. PubMed ID: 15198931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-responders.
    Brommer EJ; Barrett-Bergshoeff MM; Allen RA; Schicht I; Bertina RM; Schalekamp MA
    Thromb Haemost; 1982 Oct; 48(2):156-61. PubMed ID: 6817444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings: Regional differences in the sensitivity to several bioactive peptides in the venous system of dog.
    Tsuru H; Ishikawa N; Shigei T
    Jpn J Pharmacol; 1974; 24(0):s:76. PubMed ID: 4365079
    [No Abstract]   [Full Text] [Related]  

  • 38. Conformational studies of oxytocin, lysine vasopressin, arginine vasopressin, and arginine vasotocin by carbon-13 nuclear magnetic resonance spectroscopy.
    Walter R; Prasad KU; Deslauriers R; Smith IC
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2086-90. PubMed ID: 4516207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia.
    Walter R; Hoffman PL; Flexner JB; Flexner LB
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4180-4. PubMed ID: 1060098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research.
    McEwen BB
    Adv Pharmacol; 2004; 50():531-92, 655-708. PubMed ID: 15350270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.